Question 1

How does DataOps Suite validate clinical trial data pipelines to ensure subject-level data integrity across EDC, CTMS, and data warehouse systems?

Accepted Answer

DataOps Suite validates clinical data pipelines by performing source-to-target comparisons at the subject record level — confirming every subject enrolled in the CTMS has a corresponding EDC record, adverse event records arrived completely in the data warehouse, and derived variables such as calculated age, visit day numbers, and lab reference range flags were computed correctly. Any subject record where a value was altered, missing, or incorrectly derived is flagged with the subject identifier, visit, variable name, source value, and warehouse value — giving the data management team a targeted list of discrepancies to investigate before clinical database lock.

Question 2

How does DataOps Suite support 21 CFR Part 11 compliance requirements for validated computerized systems in pharmaceutical data pipelines?

Accepted Answer

DataOps Suite supports Part 11 compliance by producing timestamped, immutable validation test results that document which data was tested, which rules were applied, what the source and target values were, and whether the comparison passed or failed — creating an electronic audit trail for every pipeline validation run. Validation test plans are version-controlled and can be stored in the organization's change-controlled documentation system. Role-based access controls restrict who can create, modify, and execute validation test plans, satisfying Part 11 access control requirements for validated computerized systems in regulated pharmaceutical environments.

Question 3

How does DataOps Suite validate reference data consistency for life sciences coding systems such as MedDRA, WHODrug, and ICD across clinical and regulatory reporting pipelines?

Accepted Answer

DataOps Suite's reference data testing validates that coding dictionary versions are consistent and up to date across clinical data pipelines — checking every adverse event term resolves to a valid current MedDRA preferred term and system organ class, every medication name resolves to a valid WHODrug record, and no records contain retired or superseded codes from a previous dictionary version. Any record containing an invalid, retired, or version-mismatched code is flagged with the subject ID, event record, and specific code value, enabling the medical coding team to recode affected records before the regulatory submission dataset is finalized.

Question 4

How does DataOps Suite automate ETL testing for pharmaceutical data migrations when moving from legacy clinical data management systems to modern cloud platforms?

Accepted Answer

DataOps Suite automates migration validation by first profiling the legacy source data to establish baseline counts, distributions, and value ranges for every data domain — demographics, adverse events, laboratory results, vital signs, and concomitant medications. After migration, it performs a row-level comparison for every subject record in every study domain, identifying any record where a value was altered, truncated, or lost. The validation covers both structured tabular data and associated metadata — confirming dataset labels, variable attributes, and controlled terminology assignments were preserved — producing documented evidence of migration completeness for inclusion in regulatory authority validation reports.

Question 5

How does DataOps Suite validate CDISC SDTM and ADaM dataset generation pipelines for regulatory submissions?

Accepted Answer

DataOps Suite validates SDTM and ADaM transformation pipelines by defining source-to-target test cases for each domain and dataset, comparing generated values against the expected transformation output specified in the study's Data Conversion Specifications. Any SDTM or ADaM record where a derived variable was computed incorrectly — such as an AEOUT flag not matching the adverse event resolution date logic, or an AVAL numeric result incorrectly scaled during unit conversion — is flagged with the subject ID, dataset, variable name, expected value, and actual value, enabling the statistical programming team to correct the transformation defect before the dataset is included in the regulatory submission package.

Question 6

How does DataOps Suite validate pharmacovigilance data pipelines that feed adverse event reporting systems such as Argus or ARISg?

Accepted Answer

DataOps Suite validates pharmacovigilance intake and loading pipelines by confirming completeness — that every ICSR from each intake source arrived in the safety database without records being silently dropped; accuracy — that patient demographics, suspect drug details, adverse event terms, and seriousness criteria were correctly mapped into the Argus or ARISg data model; and timeliness — that the pipeline processes each ICSR within the SLA window required to meet the 15-day expedited reporting clock for serious unexpected adverse reactions. Any ICSR where a safety-relevant field was incorrectly mapped or a record failed to load within the required timeframe is flagged immediately.

Question 7

How does DataOps Suite validate life sciences BI dashboards used for clinical operations, safety surveillance, and commercial analytics?

Accepted Answer

DataOps Suite's BI Validator validates life sciences dashboards by comparing values displayed in each report visual — enrollment rates by site, cumulative adverse event counts by system organ class, or market share percentages by therapy area — directly against the underlying data warehouse using SQL. Any dashboard metric not matching the source data is flagged with the specific visual, dashboard name, displayed value, and correct source value. Validations run automatically after every ETL pipeline refresh, ensuring clinical operations teams, pharmacovigilance reviewers, and commercial leadership always view accurate data before any data review meeting, safety board, or commercial strategy session.

Question 8

How does DataOps Suite help life sciences organizations validate data quality for real-world evidence (RWE) studies that aggregate data from multiple healthcare sources?

Accepted Answer

DataOps Suite applies comprehensive data quality rules to aggregated RWE datasets — completeness checks for key variables such as diagnosis codes, medication exposure dates, and outcome events; uniqueness checks to detect duplicate patient records that would inflate the study population; validity checks confirming ICD and NDC codes fall within expected drug and disease categories; and cross-source consistency checks confirming patients present in both EHR and claims datasets have consistent demographic records across sources. These quality checks run on every data refresh, ensuring the study team works with a continuously validated, documented-quality dataset throughout the study conduct period.

Question 9

How does DataOps Suite validate ETL pipelines in pharmaceutical manufacturing and quality management systems to support GxP data integrity requirements?

Accepted Answer

DataOps Suite validates ETL pipelines moving manufacturing batch records, laboratory analytical results, and quality event data from LIMS, MES, and QMS platforms into the enterprise data warehouse — confirming every batch record, laboratory result, and deviation record arrived with all required fields populated and all values preserved correctly. Timestamped validation evidence is produced for each pipeline run. Any record where a GxP-critical field such as a batch number, analytical result value, specification limit, or investigator signature timestamp was altered or lost is flagged immediately, enabling the quality team to initiate a data integrity investigation before affected records are used in batch disposition decisions or regulatory submissions.

Question 10

How does DataOps Suite automate regression testing of Tableau reports used by pharmaceutical commercial and medical affairs teams after data pipeline updates?

Accepted Answer

DataOps Suite automates regression testing of Tableau reports by capturing a baseline snapshot of all dashboard metric values before a pipeline change, then re-executing the same dashboards after deployment and comparing new output against the baseline. Any metric returning a different value after the pipeline update — caused by a changed ETL transformation, modified aggregation, or data model restructuring — is flagged as a regression with the specific dashboard, affected metric, pre-change value, and post-change value. This gives commercial analytics and medical affairs teams documented evidence of exactly which reports were impacted, enabling them to determine whether the difference is an expected improvement or an unintended regression requiring correction before distribution to field teams or senior leadership.

Use Case

Cloud

Analytics

Industry

Academy

Support

Use Case

Cloud

Analytics

Industry

Academy

Support

Life Sciences

Life Sciences Solutions

ETL in Life Science

Benefits of ETL in Life Science

Insights through BI Testing

Key Aspects of BI Testing in Life Science

Elevating Operations with Reference Data Testing:

Case Studies

How a Pharma Leader Automated Tableau Testing for Reliable Reports and Lower QA Costs

How a French Consumer Brand Automated Testing and Cut Migration Time by 60%

Scaling APCD Data Quality Across States with Automation

Trusted Data Summit

❝ Listen to Donald Farmer from Treehive Strategy talk about Data Integrity and The Human Element at the Trusted Data Summit 2023 by Datagaps ❞

Signup for a free trial of ETL Validator

Resources

Solutions

Data Testing Concepts

Products

Download Datasheet

Download Datasheet

Download Datasheet

Download Datasheet

Download Datasheet

Data Quality Monitor

Continuously assess, score, and improve your enterprise data quality using rule-based and AI-powered validation

Automated Data Quality Checks at Scale

AI-Driven Anomaly Detection and Alerts

Low-Code Rule Configuration with Data Rule Wizard

Graphical Scoring and Monitoring Dashboard

CI/CD and Cloud Integration Ready

Test Data Manager

Generate high-quality synthetic test data securely while maintaining regulatory compliance with HIPAA, GDPR, and CCPA

AI-Powered Synthetic Test Data Generation

Reduced Cost and Time for Test Data Preparation

Support for Diverse Data Formats and Models

Secure, Policy-Driven Data Masking

Flexible Deployment Across Cloud or On-Prem

ETL Testing

Maximize the efficiency, quality, and reliability of your data pipelines through intelligent automation, validation, and scalability.

100% Data Validation Across Pipelines

Accelerated Migration and QA Cycles

Automated Metadata and Transformation Testing

Seamless Collaboration and Governance

Low-Code/No-Code Test Creation with AI

BI Validator

Ensure accuracy, performance, and security of your Business Intelligence dashboards and reports across platforms like Tableau, Power BI, and Oracle Analytics

Automated Regression Testing Across BI Reports

Cross-Platform Validation of Reports and Dashboards

Performance and Load Testing for BI Assets

Access and Security Validation

Aesthetic and Metadata Change Detection

Use Case

Cloud

Analytics

Industry

Academy

Support

Partner with us

Choose Your Plan